FDA USER FEE REPORTS TO CONGRESS: "SO FAR, SO GOOD,"
Executive Summary
FDA USER FEE REPORTS TO CONGRESS: "SO FAR, SO GOOD," House Energy & Commerce Committee health staffer Kay Holcombe told the Drug Information Association annual meeting in Washington, D.C. June 6. Congress received FDA's report on the implementation of the drug user fee act on June 3, Holcombe said, about "six months late" ("The Pink Sheet" May 16, p. 5). The report is "a very positive sign that indeed there is a commitment at FDA to meet the goals that it committed to meet" when the drug user fee act passed in June 1992, Holcombe said.